Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$0.45
-$0.03-6.55%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 81.16% | 92.83% | 65.23% | 142.72% | 82.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.73% | 54.84% | 51.43% | 103.33% | 61.58% |
| Operating Income | -20.73% | -54.84% | -51.43% | -103.33% | -61.58% |
| Income Before Tax | -3.39% | -28.18% | -16.53% | -68.75% | -42.43% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.39% | -28.18% | -16.53% | -68.75% | -42.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.39% | -28.18% | -16.53% | -68.75% | -42.43% |
| EBIT | -20.73% | -54.84% | -51.43% | -103.33% | -61.58% |
| EBITDA | -17.64% | -51.17% | -51.49% | -103.51% | -61.71% |
| EPS Basic | 92.83% | 86.14% | 80.95% | 33.28% | 15.90% |
| Normalized Basic EPS | 91.88% | 84.58% | 79.40% | 41.92% | 18.23% |
| EPS Diluted | 92.99% | 86.41% | 79.17% | 31.16% | 13.93% |
| Normalized Diluted EPS | 91.88% | 84.58% | 79.40% | 41.92% | 18.23% |
| Average Basic Shares Outstanding | 1,334.43% | 1,322.72% | 1,056.16% | 457.94% | 148.44% |
| Average Diluted Shares Outstanding | 1,334.43% | 1,322.72% | 1,056.16% | 457.94% | 148.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |